Evidence map›Paper›PMID 35265207›Full record

ArticleTheranostics2022

Non-invasive photobiomodulation treatment in an Alzheimer Disease-like transgenic rat model.

Luodan Yang, Chongyun Wu, Emily Parker, Yong Li, Yan Dong, Lorelei Tucker, Darrell W Brann, Hung Wen Lin, Quanguang Zhang

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Transcranial laser therapy for acute ischaemic stroke.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Transcranial near-infrared therapy restores synaptic resilience by reshaping signaling landscapes in sleep-deprived tauopathy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Luodan YangDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, 1501 Kings Highway, LA 71103 USA.
Chongyun WuMedical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912 USA.
Emily ParkerMedical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912 USA.
Yong LiMedical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912 USA.
Yan DongMedical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912 USA.
Lorelei TuckerMedical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912 USA.
Darrell W BrannMedical College of Georgia, Augusta University, 1120 15th Street, Augusta, GA 30912 USA.
Hung Wen LinDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, 1501 Kings Highway, LA 71103 USA.
Quanguang ZhangDepartment of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, 1501 Kings Highway, LA 71103 USA.
Louisiana State University Health Sciences Center Shreveport · US

Funding

Low Level Laser Therapy in Alzheimer's DiseaseRF1AG058603 · NIA · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ZHANG, QUANGUANG · 2018 to 2018
$1.9M
NIA NIH HHS RF1 AG058603
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common form of dementia in the elderly, causing neuronal degeneration and cognitive deficits that significantly impair independence and quality of life for those affected and their families. Though AD is a major neurodegenerative disease with vast avenues of investigation, there is no effective treatment to cure AD or slow disease progression. The present work evaluated the therapeutic effect of long-term photobiomodulation (PBM) treatment with continuous-wave low-level laser on AD and its underlying mechanism.

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesNeuroprotective AgentsAgedAmyloid beta-PeptidesAnimalsDisease Models, AnimalHumansPlaque, AmyloidQuality of LifeRatsRats, TransgenicAmyloid beta-PeptidesNeuroprotective AgentsMicroglia recruitmentMitochondriaNeuronal hemoglobinPhotobiomodulationTgF344 rats

Identifiers

PMID35265207
PMCPMC8899582
OpenAlexW4213290930

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.